AirSculpt Technologies (AIRS) Stock Analysis & Winston Score

AirSculpt Technologies runs a chain of cosmetic surgery centers across the United States and Canada. The company specializes in one thing: its own patented body contouring procedure called AirSculpt, which removes fat without traditional liposuction tools or general anesthesia. It targets adults who want elective fat removal and body shaping and do not need a hospital setting to get it. The company makes money by charging patients directly for each procedure, so revenue depends on how many people walk through the door and pay out of pocket — insurance does not cover cosmetic surgery. AirSculpt operates dozens of centers in major US cities, with a small presence in Canada and Europe. Its patented technique and branded experience give it some differentiation from general plastic surgery practices. The main risk is that consumers cut back on expensive elective procedures when the economy slows, and the company is currently unprofitable, meaning it needs steady volume growth to reach sustainable earnings.